Colgate-Palmolive’s stock slips on weaker-than-expected guidance despite Q4 profit beat
Colgate-Palmolive’s CEO noted that the company hit an “exciting milestone,” but it wasn’t enough to lift the stock premarket.
Colgate-Palmolive Q4: EPS Beat, Sales Miss, Cautious FY25 Forecast And More
Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic sales rose by 4.3%, and non-GAAP EPS of $0.91 surpassed the consensus. The company expects flat FY25 sales.
Colgate-Palmolive: Q4 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Colgate-Palmolive Co. (CL) on Friday reported fourth-quarter net income of $739 million. The New York-based company said it had profit of 90 cents per share. Earnings, adjusted for non-recurring costs, came to 91 cents per share.
Colgate-Palmolive’s stock slips despite Q4 profit beat and revenue ‘milestone’
Colgate-Palmolive Co. shares are down 0.7% in premarket trades despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue milestone.
Colgate-Palmolive Co. Q4 Profit Increases, Beats Estimates
Colgate-Palmolive Co. (CL) revealed earnings for its fourth quarter that increased from the same period last year and beat the
Colgate-Palmolive (NYSE:CL) Misses Q4 Revenue Estimates
Consumer products company Colgate-Palmolive (NYSE:CL) in Q4 CY2024, with sales flat year on year at $4.94 billion. Its non-GAAP profit of $0.91 per share was 2.3% above analysts’ consensus estimates.
Colgate-Palmolive EPS Up, Revenue Lags
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
Colgate-Palmolive's lackluster guidance upstages solid Q4 results
The lackluster guidance upstaged an otherwise solid quarter for the company. For the reported quarter, Colgate ( NYSE: CL) earned an adjusted profit of $0.91, up 4.5% from a year ago and 2 cents better than expected.
Colgate-Palmolive stock analysis: overvalued ahead of earnings
The Colgate-Palmolive stock price remains in a deep correction as investors wait for the fourth-quarter results. CL has plunged by over 17%, bringing its market cap to about $73 billion. So, is Colgate a good stock to buy the dip in?
Colgate-Palmolive Sees FY25 Earnings, Organic Sales Growth - Update
While reporting financial results for the fourth quarter on Friday, Colgate-Palmolive Co. (CL) initiated its earnings, adjusted ...
Colgate-Palmolive 4Q Sales Slip Lower; 2025 Sales Seen Roughly Flat
Colgate-Palmolive forecast 2025 sales to be roughly flat from last year; sales came in at $20.10 billion in 2024. Write to Denny Jacob at [email protected] ...
Colgate-Palmolive sees weaker annual sales growth on demand slowdown
The company's net sales in Latin America, a major revenue contributing region, fell 7.2 per cent and dropped 1 per cent in ...
Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Would you like to be notified of the latest news and updates on the stock market?
Analysts Offer Insights on Consumer Goods Companies: Colgate-Palmolive (CL) and Lamb Weston Holdings (LW)
Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Colgate-Palmolive (CL – Research Report) ...
bovnews22h
Why Did Stifel Give Colgate-Palmolive Co (CL) Stock Hold Rating?
Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $89.57 which represents a decrease of $-0.29 or -0.32% from the prior close of $89.86. The stock opened at $90.11 and touched a low of ...
Is Colgate-Palmolive Company (CL) the Best Diversified Dividend Stock to Buy Now?
We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a ...
Colgate Palmolive India's Q3 profit misses estimates on moderating demand
Colgate Palmolive (India) reported a third-quarter profit that came in below market estimates on Tuesday, hurt by dwindling demand from urban consumers and higher expenses.
Colgate-Palmolive (NYSE:CL) Shares Sold by Geneos Wealth Management Inc.
Geneos Wealth Management Inc. lessened its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 3.3% during the ...